Gene Therapy Research Program for Arthritis and Related Conditions
Gene Therapy Research Program for Arthritis and Related Conditions

Gene Therapy

At a Glance 

  • Goal is to deliver a protein therapy locally to the joint providing sustained efficacy while avoiding key side effects typically associated with systemic therapy
  • Arthritis is leading cause of disability in the U.S. affecting > 52 million adults and 300,000 children1
  • Collaboration combines Fibrocell’s expertise in autologous fibroblast technology with Intrexon’s cellular engineering to develop localized, engineered cell-based therapies
product-development

Explore Advocacy & Educational Resources


1Centers for Disease Control and Prevention: http://www.cdc.gov/chronicdisease/resources/publications/aag/arthritis.htm. Accessed 01.18.16.